Moreover, ASC treatment increased anti-inflammatory cytokines, IL-10 and TGF-β, in the BALF and LLNs, which ultimately led to decreased lung eosinophil infiltration, goblet cell hyperplasia, allergy-specific Th2 cytokines, and Ig production. Here, IL10 is linked to allergic disease.